The Ink4/Arf locus is a barrier for iPS cell reprogramming
about
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilityEstablishment of induced pluripotent stem cells from centenarians for neurodegenerative disease researchPrimordial germ cells in miceInterplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulationUbiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressorSwitching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologiesTumor suppressors: enhancers or suppressors of regeneration?Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruningCellular senescence and tumor suppressor gene p16Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspectiveDirect cell reprogramming is a stochastic process amenable to accelerationInduced neuronal cells: how to make and define a neuronHallmarks of progeroid syndromes: lessons from mice and reprogrammed cellsRetinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategiesEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionPluripotent Stem Cells: Current Understanding and Future DirectionsNeuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosisCell-based therapies of liver diseases: age-related challengesConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsEnergy metabolism plasticity enables stemness programsReprogramming of gastrointestinal cancer cellsMYC and the art of microRNA maintenanceMetastatic cancer stem cells: from the concept to therapeuticsShared mechanisms in stemness and carcinogenesis: lessons from oncogenic virusesmicroRNAs as novel regulators of stem cell pluripotency and somatic cell reprogrammingThe genomic stability of induced pluripotent stem cellsThe roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generationHematopoietic stem cell engineering at a crossroadsThe cell cycle and pluripotencyOvercoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and qualityDirect lineage conversion: induced neuronal cells and induced neural stem cellsCellular reprogramming in skin cancerDynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cellsExamination of the expanding pathways for the regulation of p21 expression and activity.Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseasesIn vitro models of cancer stem cells and clinical applicationsEmerging Non-Canonical Functions and Regulation by p53: p53 and StemnessPresent and future challenges of induced pluripotent stem cellsReprogramming with Small Molecules instead of Exogenous Transcription FactorsLost highway(s): barriers to postnatal cortical neurogenesis and implications for brain repair
P2860
Q21183968-EA186021-6047-4E7F-9D0C-F8627FC208F4Q21560780-CDE403F5-28C0-49F4-8BFB-5BC2633CE533Q22065789-E7A08FC1-4C86-4508-9B1F-7EDF32233B4DQ24322448-510BFA4B-031E-4DF6-B843-C6D88B8CE8B7Q24337508-4AABAB6A-897F-424F-B888-34F1BB336878Q24617141-8E063FAD-E782-4515-9E05-98640BB3D827Q24618747-90DDF4D2-0EDA-4393-A792-16056ED20700Q24619000-AEB7E9EA-8377-42E1-9182-75FCC8F95C98Q24629853-EDB820EC-FC7F-4559-81E7-B5AEE9E8B7C9Q24633489-3101FFC2-425C-4BDF-B0FF-84A2C48A879CQ24644898-3843A831-547A-4161-99F9-E9278D6D17F4Q26269839-86EB8670-7C83-40B3-B82F-D68389E5D258Q26740026-7AC83E5E-4A60-42D1-900F-4633835FCF89Q26750380-D28F6E89-1AF9-49BE-AD2C-8BE11F23BF8DQ26766149-C61AD0B9-850E-4C3F-879D-CCCB80F31848Q26769981-C1B1305B-24D7-44A3-9FF3-0694128C4042Q26774960-F45667D3-BA49-4FBD-B192-B4DE2153181EQ26776328-FF52D881-4CC4-4C25-9D63-F933C3F4F17FQ26799570-8E415747-A722-4124-8697-EB9D252FB7FFQ26822945-84A3AF6E-13E7-4BCA-9884-7E67FEE8E900Q26824284-73C131E5-AA46-46B2-9F75-6C1B72EC8761Q26825457-2135CEA7-5556-45E8-96BE-4453E60F17A1Q26850739-8F6D2D23-C9BD-43CB-92D9-73DB1B0CA879Q26863339-0D8F7340-F9D4-48C5-85D9-9BCCF30C802FQ26997070-02440ADF-79DB-458D-BAAC-93EA1E7806B6Q26998764-A850A85E-0BEA-405E-9774-03C083E33B84Q26999027-8B94E9D6-6947-4F62-B2BF-356247445189Q27001570-FD1C2217-88AD-447E-AE63-ECBAEF983105Q27009037-162B9906-055C-471A-AF76-16D418A80D09Q27014026-0D928A44-4162-4CE0-A9AE-1E48ABAA1427Q27025605-FDFAD89F-EF1C-4D08-81BE-E7263C463CA7Q27027468-A5848E6E-F3BC-46FA-89EC-C10E76F0D42CQ27310384-E62BC31C-1348-48AB-8DF0-39F1D7AEAF2EQ27692024-7AC54E58-C85B-4B4A-9B7E-310F6FFFDB42Q28073204-D9B93EF3-E1F8-431E-A950-603EA0CF7D90Q28076101-C68ED2C2-6EE0-477C-94CF-025836092709Q28077156-BE2E423E-5517-4AFB-BFF0-92BB57D29E01Q28082747-9FD2297C-1A5A-4C11-A8FE-4622C308A82EQ28084394-72F996BE-6A92-476E-B347-731ABD4BAD9CQ28084984-B0CB6D24-0571-424C-BC03-D7529C91D240
P2860
The Ink4/Arf locus is a barrier for iPS cell reprogramming
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@ast
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@en
type
label
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@ast
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@en
prefLabel
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@ast
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
The Ink4/Arf locus is a barrier for iPS cell reprogramming
@en
P2093
Marta Cañamero
Sagrario Ortega
P2860
P2888
P304
P3181
P356
10.1038/NATURE08290
P407
P577
2009-08-09T00:00:00Z
P6179
1045815818